237 related articles for article (PubMed ID: 20299338)
1. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.
Kovesdy CP; Ureche V; Lu JL; Kalantar-Zadeh K
Nephrol Dial Transplant; 2010 Sep; 25(9):3003-11. PubMed ID: 20299338
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
Sumida K; Molnar MZ; Potukuchi PK; Thomas F; Lu JL; Obi Y; Rhee CM; Streja E; Yamagata K; Kalantar-Zadeh K; Kovesdy CP
Nephrol Dial Transplant; 2018 Feb; 33(2):264-273. PubMed ID: 28064159
[TBL] [Abstract][Full Text] [Related]
3. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.
Rhee CM; Molnar MZ; Lau WL; Ravel V; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
Perit Dial Int; 2014; 34(7):732-48. PubMed ID: 24385335
[TBL] [Abstract][Full Text] [Related]
4. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
[TBL] [Abstract][Full Text] [Related]
5. Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis.
Bergman A; Qureshi AR; Haarhaus M; Lindholm B; Barany P; Heimburger O; Stenvinkel P; Anderstam B
J Nephrol; 2017 Apr; 30(2):255-262. PubMed ID: 26994005
[TBL] [Abstract][Full Text] [Related]
6. The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease.
Kim DW; Hwang SY; Nam YJ; Kim D; Shin SJ; Yoon HE
Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1476-1483. PubMed ID: 32586735
[TBL] [Abstract][Full Text] [Related]
7. A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan.
Maruyama Y; Taniguchi M; Kazama JJ; Yokoyama K; Hosoya T; Yokoo T; Shigematsu T; Iseki K; Tsubakihara Y
Nephrol Dial Transplant; 2014 Aug; 29(8):1532-8. PubMed ID: 24642419
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis.
Fan Y; Jin X; Jiang M; Fang N
Sci Rep; 2017 Oct; 7(1):13224. PubMed ID: 29038525
[TBL] [Abstract][Full Text] [Related]
9. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
Nakano C; Hamano T; Fujii N; Obi Y; Matsui I; Tomida K; Mikami S; Inoue K; Shimomura A; Nagasawa Y; Okada N; Tsubakihara Y; Rakugi H; Isaka Y
Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
[TBL] [Abstract][Full Text] [Related]
10. High levels of both serum gamma-glutamyl transferase and alkaline phosphatase are independent preictors of mortality in patients with stage 4-5 chronic kidney disease.
Caravaca-Fontán F; Azevedo L; Bayo MÁ; Gonzales-Candia B; Luna E; Caravaca F
Nefrologia; 2017; 37(3):267-275. PubMed ID: 28648203
[TBL] [Abstract][Full Text] [Related]
11. Bone alkaline phosphatase and mortality in dialysis patients.
Drechsler C; Verduijn M; Pilz S; Krediet RT; Dekker FW; Wanner C; Ketteler M; Boeschoten EW; Brandenburg V;
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1752-9. PubMed ID: 21597029
[TBL] [Abstract][Full Text] [Related]
12. Serum Alkaline Phosphatase Levels are Not Associated with Increased Death Risk in Prevalent Hemodialysis Patients: 5-Year Experience in a Single Hemodialysis Center.
Zhu JG; Cheng BC; Lee WC; Li LC; Lee CH; Long G; Chen JB
Kidney Blood Press Res; 2016; 41(4):498-506. PubMed ID: 27467278
[TBL] [Abstract][Full Text] [Related]
13. Serum Alkaline Phosphatase Levels Predict Infection-Related Mortality and Hospitalization in Peritoneal Dialysis Patients.
Hwang SD; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
PLoS One; 2016; 11(6):e0157361. PubMed ID: 27310428
[TBL] [Abstract][Full Text] [Related]
14. Impact of age on survival predictability of bone turnover markers in hemodialysis patients.
Lertdumrongluk P; Lau WL; Park J; Rhee CM; Kovesdy CP; Kalantar-Zadeh K
Nephrol Dial Transplant; 2013 Oct; 28(10):2535-45. PubMed ID: 23904397
[TBL] [Abstract][Full Text] [Related]
15. Serum alkaline phosphatase levels correlate with long-term mortality solely in peritoneal dialysis patients with residual renal function.
Zhan X; Yang Y; Chen Y; Wei X; Xiao J; Zhang L; Yan C; Qiu P; Liu S; Hu Q; Chen Q; Wang Y
Ren Fail; 2019 Nov; 41(1):718-725. PubMed ID: 31409217
[No Abstract] [Full Text] [Related]
16. High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients.
Chen Z; Zhang X; Han F; Xie X; Hua Z; Huang X; Lindholm B; Haarhaus M; Stenvinkel P; Qureshi AR; Chen J
Perit Dial Int; 2021 Mar; 41(2):236-243. PubMed ID: 32363998
[TBL] [Abstract][Full Text] [Related]
17. High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study.
Drechsler C; Evenepoel P; Vervloet MG; Wanner C; Ketteler M; Marx N; Floege J; Dekker FW; Brandenburg VM;
Nephrol Dial Transplant; 2015 Feb; 30(2):288-93. PubMed ID: 25248363
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population.
Taliercio JJ; Schold JD; Simon JF; Arrigain S; Tang A; Saab G; Nally JV; Navaneethan SD
Am J Kidney Dis; 2013 Oct; 62(4):703-10. PubMed ID: 23769134
[TBL] [Abstract][Full Text] [Related]
19. The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease.
Haarhaus M; Fernström A; Qureshi AR; Magnusson P
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959954
[TBL] [Abstract][Full Text] [Related]
20. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].
Jean G; Souberbielle JC; Granjon S; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Chazot C
Nephrol Ther; 2013 Jun; 9(3):154-9. PubMed ID: 23545236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
